Logo image of SSY

SUNLINK HEALTH SYSTEMS INC (SSY) Stock Fundamental Analysis

NYSEARCA:SSY - NYSE Arca - US86737U1025 - Common Stock - Currency: USD

0.8802  +0.03 (+3.55%)

Fundamental Rating

3

Taking everything into account, SSY scores 3 out of 10 in our fundamental rating. SSY was compared to 102 industry peers in the Health Care Providers & Services industry. While SSY has a great health rating, there are worries on its profitability. SSY does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year SSY was profitable.
In the past year SSY has reported a negative cash flow from operations.
In the past 5 years SSY reported 4 times negative net income.
In multiple years SSY reported negative operating cash flow during the last 5 years.
SSY Yearly Net Income VS EBIT VS OCF VS FCFSSY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

SSY has a Return On Assets of 9.87%. This is amongst the best in the industry. SSY outperforms 94.12% of its industry peers.
The Return On Equity of SSY (12.86%) is better than 80.39% of its industry peers.
Industry RankSector Rank
ROA 9.87%
ROE 12.86%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SSY Yearly ROA, ROE, ROICSSY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

SSY's Profit Margin of 5.55% is amongst the best of the industry. SSY outperforms 80.39% of its industry peers.
SSY's Gross Margin of 43.05% is fine compared to the rest of the industry. SSY outperforms 71.57% of its industry peers.
In the last couple of years the Gross Margin of SSY has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 5.55%
GM 43.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.82%
GM growth 5Y-5.67%
SSY Yearly Profit, Operating, Gross MarginsSSY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

SSY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SSY has been increased compared to 1 year ago.
The number of shares outstanding for SSY has been increased compared to 5 years ago.
SSY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SSY Yearly Shares OutstandingSSY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M
SSY Yearly Total Debt VS Total AssetsSSY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 2.64 indicates that SSY is not a great score, but indicates only limited risk for bankruptcy at the moment.
SSY has a Altman-Z score of 2.64. This is comparable to the rest of the industry: SSY outperforms 57.84% of its industry peers.
There is no outstanding debt for SSY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.64
ROIC/WACCN/A
WACC9.15%
SSY Yearly LT Debt VS Equity VS FCFSSY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 3.91 indicates that SSY has no problem at all paying its short term obligations.
The Current ratio of SSY (3.91) is better than 91.18% of its industry peers.
A Quick Ratio of 3.50 indicates that SSY has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.50, SSY belongs to the best of the industry, outperforming 90.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.91
Quick Ratio 3.5
SSY Yearly Current Assets VS Current LiabilitesSSY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

SSY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 125.41%, which is quite impressive.
Looking at the last year, SSY shows a very negative growth in Revenue. The Revenue has decreased by -12.45% in the last year.
Measured over the past years, SSY shows a decrease in Revenue. The Revenue has been decreasing by -6.58% on average per year.
EPS 1Y (TTM)125.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.89%
Revenue 1Y (TTM)-12.45%
Revenue growth 3Y-7.28%
Revenue growth 5Y-6.58%
Sales Q2Q%-1.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SSY Yearly Revenue VS EstimatesSSY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 3.39, the valuation of SSY can be described as very cheap.
100.00% of the companies in the same industry are more expensive than SSY, based on the Price/Earnings ratio.
SSY's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.52.
Industry RankSector Rank
PE 3.39
Fwd PE N/A
SSY Price Earnings VS Forward Price EarningsSSY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SSY Per share dataSSY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SSY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUNLINK HEALTH SYSTEMS INC

NYSEARCA:SSY (6/6/2025, 8:04:00 PM)

0.8802

+0.03 (+3.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-14 2025-05-14
Earnings (Next)09-29 2025-09-29
Inst Owners14.13%
Inst Owner Change-19.81%
Ins Owners23.27%
Ins Owner Change0%
Market Cap6.20M
Analysts0
Price TargetN/A
Short Float %0.06%
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.39
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 0.46
P/tB 0.51
EV/EBITDA N/A
EPS(TTM)0.26
EY29.54%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS4.42
BVpS1.9
TBVpS1.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.87%
ROE 12.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 5.55%
GM 43.05%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.82%
GM growth 5Y-5.67%
F-Score4
Asset Turnover1.78
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 48.16%
Cap/Sales 3.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.91
Quick Ratio 3.5
Altman-Z 2.64
F-Score4
WACC9.15%
ROIC/WACCN/A
Cap/Depr(3y)133.35%
Cap/Depr(5y)134.66%
Cap/Sales(3y)5.57%
Cap/Sales(5y)5.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)125.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.45%
Revenue growth 3Y-7.28%
Revenue growth 5Y-6.58%
Sales Q2Q%-1.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-78.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-451.48%
OCF growth 3YN/A
OCF growth 5YN/A